Brazilian vaccine against prostate cancer begins to be tested in the USA

The CellVax vaccine promises individualized treatments. After 25 years of studies in Brazil, it received the green light from the FDA, the United States Food and Drug Administration.

"It's a journey of great resilience, of great support from various parties. To get where we are, there are literally hundreds of people who are working towards this today", says Fernando Kreutz.

💉 How does the vaccine work?

Fragments of the patient's tumor are removed. The cancer cells are expanded and modified in the laboratory. And then used to activate the patient's own immune system.

Last Tuesday, the first of a total of 280 volunteers had fragments of prostate cancer removed for research on American soil. According to Dr. Fernando, if everything goes well, the FDA may authorize the registration of the Brazilian vaccine within two years.

See video and original article at:

https://g1.globo.com/fantastico/